Erytechs Battle With Activist Investor Echoes As Pherecydes Pharma Merger Vote Comes Closer
| ERYPDelisted Stock | USD 0.78 0.04 4.88% |
Slightly above 62% of Erytech Pharma's investor base is looking to short. The analysis of current outlook of investing in Erytech Pharma SA suggests that many traders are alarmed regarding Erytech Pharma's prospects. Erytech Pharma's investing sentiment overview a quick insight into current market opportunities from investing in Erytech Pharma SA. Many technical investors use Erytech Pharma SA stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Erytech |
In February, Erytech Pharma SA announced its proposed combination with Pherecydes Pharma S.A. In June, Erytech announced that Akkadian initiated proceedings to postpone the vote, scheduled on 23 June, on the merger with Pherecydes. The merger would see Pherecydes absorbed into publicly listed Erytech, with Pherecydes shareholders receiving 15 new Erytech shares for every four of their current shares. Monday, Erytech Pharma responded to what it described as Akkadian Partners disi
Read at finance.yahoo.com
 |
Erytech Pharma Fundamental Analysis
We analyze Erytech Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Erytech Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Erytech Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Debt To Equity
Debt To Equity Comparative Analysis
Erytech Pharma is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Erytech Pharma SA Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Erytech Pharma stock to make a market-neutral strategy. Peer analysis of Erytech Pharma could also be used in its relative valuation, which is a method of valuing Erytech Pharma by comparing valuation metrics with similar companies.
Peers
Erytech Pharma Related Equities
| SRZN | Surrozen | 19.37 | ||||
| XRTX | XORTX Therapeutics | 4.96 | ||||
| ATXI | Avenue Therapeutics | 4.37 | ||||
| IKNA | Ikena Oncology | 2.37 | ||||
| UNCY | Unicycive Therapeutics | 1.47 | ||||
| ADXN | Addex Therapeutics | 1.04 | ||||
| SNGX | Soligenix | 0.60 | ||||
| MOLN | Molecular Partners | 0.17 | ||||
| NTRB | Nutriband | 1.03 | ||||
| ELYM | Eliem Therapeutics | 1.30 | ||||
| GNFT | Genfit | 1.41 | ||||
| ARMP | Armata Pharmaceuticals | 2.13 | ||||
| HCWB | HCW Biologics | 6.00 | ||||
| XCUR | Exicure | 7.81 | ||||
| APM | Aptorum Group | 8.45 |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Erytech Stock
If you are still planning to invest in Erytech Pharma SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Erytech Pharma's history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |